306-NSD2与去势抵抗性前列腺癌谱系重塑 episode artwork

EPISODE · Dec 9, 2025 · 19 MIN

306-NSD2与去势抵抗性前列腺癌谱系重塑

from 聊聊Sci

本研究探讨了去势抵抗性前列腺癌 (CRPC) 产生耐药性的机制,尤其关注其向高侵袭性的神经内分泌亚型(CRPC-NE)演变的路线。通过对小鼠和人类类器官模型进行分析,研究人员发现组蛋白甲基转移酶 NSD2 是驱动谱系可塑性并维持这种耐药神经内分泌状态的关键因子。在机制上,NSD2通过调控 H3K36me2 组蛋白标记来维持抗性,高 NSD2 表达与患者较差的总生存率显著相关。重要发现是,基因靶向或药物抑制 NSD2 能够逆转神经内分泌表型,促使细胞重新表达雄激素受体(AR)。这种逆转有效地 恢复了 CRPC 细胞对雄激素受体抑制剂恩杂鲁胺的敏感性,为治疗晚期前列腺癌提供了联合抑制 NSD2 和 AR 通路的临床前依据。References: Li J J, Vasciaveo A, Karagiannis D, et al. NSD2 targeting reverses plasticity and drug resistance in prostate cancer[J]. Nature, 2025: 1-11.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Dec 9, 2025

Embed this episode

Ready to play

306-NSD2与去势抵抗性前列腺癌谱系重塑

0:00 19:32

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 19 minutes long.

When was this 聊聊Sci episode published?

This episode was published on December 9, 2025.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!